サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1477068

腫瘍塞栓デバイスの世界市場：2033年までの機会と戦略

Tumor Embolization Devices Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 281 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
腫瘍塞栓デバイスの世界市場：2033年までの機会と戦略
出版日: 2024年05月09日
発行: The Business Research Company
ページ情報: 英文 281 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の腫瘍塞栓デバイス市場は2018年に11億4,318万米ドルと評価され、CAGR4.0％以上で2023年まで成長しました。

研究開発支出の増加

医療分野における研究開発費の増加が、これまでの腫瘍塞栓デバイス市場を牽引しました。研究開発費の増加は、腫瘍塞栓用デバイスの新規材料や設計の探求を可能にします。その結果、より効率的で効果的なデバイスが開発され、腫瘍をより的確に治療できるようになり、患者の予後改善につながります。研究開発投資は、腫瘍塞栓デバイスに高度な画像技術を統合することに貢献します。これには、MRI（磁気リソース画像）やCT（コンピュータ断層撮影）スキャンなどのリアルタイム画像モダリティの組み込みが含まれ、塞栓術中に腫瘍や周辺組織をよりよく可視化することができます。例えば、米国のデジタルマーケティング会社であるWebFXによると、医療技術企業は通常、年間収益の5.1％を研究開発プロジェクトに充てています。米国と英国の医療技術企業の研究開発費は11.5％増加しました。したがって、研究開発費の増加は、歴史的な期間における腫瘍塞栓デバイス市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 腫瘍塞栓デバイス-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポートの構造

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 腫瘍塞栓デバイス市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 放射線塞栓剤
    • 非放射性塞栓剤
  • 市場セグメンテーション：用途別
    • がん腫瘍
    • 非がん性腫瘍
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • がん治療センター
    • 外来手術センター

第7章 腫瘍塞栓デバイス市場：マクロ経済シナリオ

  • COVID-19の影響：腫瘍塞栓デバイス市場
  • ウクライナ戦争の影響、腫瘍塞栓デバイス市場
  • 高インフレの影響：腫瘍塞栓デバイス市場

第8章 主要な市場動向

  • 正確な腫瘍塞栓術のための新しいシステムまたはプラットフォームの開発
  • 腫瘍塞栓調査を推進するための戦略的提携と買収
  • がん治療のための治験薬の開発
  • 臨床試験により腫瘍塞栓療法が進歩
  • 革新的ながん治療薬の開発を支援するための資金増額

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界の腫瘍塞栓デバイス市場：セグメンテーション

  • 世界の腫瘍塞栓デバイス市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の腫瘍塞栓デバイス市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の腫瘍塞栓デバイス市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 腫瘍塞栓デバイス市場：地域・国別分析

  • 世界の腫瘍塞栓デバイス市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の腫瘍塞栓デバイス市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Merit Medical Systems Inc.
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Siemens Healthineers AG
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Cook Medical LLC
    • 会社概要
    • 製品・サービス
    • 財務概要
  • AngioDynamics Inc.
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要
  • Boston Scientific Corporation
    • 会社概要
    • 製品・サービス
    • 事業戦略
    • 財務概要

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • MedTech Acquisition Corporation Acquired TriSalus Life Sciences
  • Grand Pharmaceutical Group Acquired BlackSwan Vascular
  • Boston Scientific Corporation Acquired Obsidio
  • Hologic Acquired Acessa Health
  • Terumo Corporation Acquired Quirem Medical

第23章 機会と戦略

  • 2028年の世界市場：新たな機会を提供する国
  • 2028年の世界市場：新たな機会を提供するセグメント
  • 2028年の世界市場：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 腫瘍塞栓デバイス市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1102

Tumor embolization devices are specialized medical tools used in the process of embolization, a minimally invasive procedure that blocks blood vessels to prevent blood flow to cancerous tumors or other abnormal growths.

The tumor embolization devices market consists of sales, by entities (organizations, sole traders or partnerships), of tumor embolization devices that are crucial in the treatment of various types of tumors, both cancerous and non-cancerous, by delivering embolic agents directly to the site of the tumor.

The global tumor embolization devices market was valued at $1,143.18 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increased Research And Development Spending

Rising research and development spending in the medical sector drove the tumor embolization devices market in the historic period. Increased research and development funding allows for the exploration of novel materials and designs for tumor embolization devices. This results in the development of more efficient and effective devices that can better target and treat tumors, leading to improved patient outcomes. R&D investments can contribute to the integration of advanced imaging technologies into tumor embolization devices. This may include the incorporation of real-time imaging modalities, such as MRI (magnetic resource imaging) or CT (computed tomography) scans, providing better visualization of tumors and surrounding tissues during the embolization procedure. For instance, according to the WebFX a US-based digital marketing agency, medical technology companies generally allocate 5.1% of their yearly revenue towards research and development projects. R&D expenditures for MedTech businesses in the US and the UK increased by 11.5%. Therefore, the increased research and development spending drove the growth of the tumor embolization devices market during the historic period.

Development Of New Systems Or Platforms For Precise Tumor Embolization

Companies in the tumor embolization devices market are focusing on developing innovative systems or platforms for precise tumor embolization to strengthen their position in the market. For instance, in November 2023, Fluidx Medical Technology, a US-based medical device company, developing embolic material and other technologies, revealed information about their new ULTRA embolic platform, which is intended to make therapeutic embolization procedures safer, better and faster. The ULTRA platform is intended to meet the demands of patients requiring moderately distal to proximal tumor embolization. Additionally, in June 2022, Siemens Healthineers, a Germany-based medical technology company that provides healthcare solutions and services, introduced Artis, a new, ceiling-mounted icono ceiling angiography system for precise tumor embolization. The new Artis icono ceiling assists medical personnel in performing with an extremely high level of precision, by combining mechanical flexibility, high positioning accuracy and intelligent operations.

The global tumor embolization devices market is concentrated, with a few players operating in the market. The top ten competitors in the market made up 42.39% of the total market in 2022.

Tumor Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tumor embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tumor embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tumor embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tumor embolization devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tumor embolization devices market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for tumor embolization devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Radio embolic Agents; Non-Radioactive Embolic Agents
  • 2) By Application: Cancer Tumors; Noncancerous Tumors
  • 3) By End User: Hospitals; Cancer Treatment Centers; Ambulatory Surgical Centers
  • Companies Mentioned: Merit Medical Systems Inc.; Siemens Healthineers AG; Medical LLC; Angio Dynamics Inc.; Boston Scientific Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Canada; USA; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tumor embolization devices indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Tumor Embolization Devices- Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Tumor Embolization Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Radio embolic Agents
    • 6.4.2 Non-radioactive Embolic Agents
  • 6.5 Market Segmentation By Application
    • 6.5.1 Cancer Tumors
    • 6.5.2 Noncancerous Tumors
  • 6.6 Market Segmentation By End User
    • 6.6.1 Hospitals
    • 6.6.2 Cancer Treatment Centers
    • 6.6.3 Ambulatory Surgical Centers

7 Tumor Embolization Devices Market - Macro Economic Scenario

  • 7.1 COVID-19 Impact On The Tumor Embolization Devices Market
  • 7.2 Impact Of The War In Ukraine On The Tumor Embolization Devices Market
  • 7.3 Impact Of High Inflation On The Tumor Embolization Devices Market

8 Major Market Trends

  • 8.1 Development Of New Systems Or Platforms For Precise Tumor Embolization
  • 8.2 Strategic Collaborations And Acquisitions To Advance Tumor Embolization Research
  • 8.3 Development Of Investigational Products For Carcinoma Treatment
  • 8.4 Clinical Trials Are Advancing Tumor Embolization Therapy
  • 8.5 Increasing Funding To Support Development Of Innovative Cancer Therapeutics

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Tumor Embolization Devices Market Segmentation

  • 10.1 Global Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tumor Embolization Devices Market, Regional and Country Analysis

  • 11.1 Global Tumor Embolization Devices Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Tumor Embolization Devices Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Tumor Embolization Devices Market: Country Analysis
  • 12.6 Summary
  • 12.7 China Market
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Tumor Embolization Devices Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Tumor Embolization Devices Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Tumor Embolization Devices Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Major Companies
  • 16.2 South America Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Tumor Embolization Devices Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Merit Medical Systems Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Siemens Healthineers AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Cook Medical LLC
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 AngioDynamics Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Boston Scientific Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 MedTech Acquisition Corporation Acquired TriSalus Life Sciences
  • 22.2 Grand Pharmaceutical Group Acquired BlackSwan Vascular
  • 22.3 Boston Scientific Corporation Acquired Obsidio
  • 22.4 Hologic Acquired Acessa Health
  • 22.5 Terumo Corporation Acquired Quirem Medical

23 Opportunities And Strategies

  • 23.1 Global Tumor Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Tumor Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Tumor Embolization Devices Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Tumor Embolization Devices Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer